PDK3 and pancreatic neoplasm: E2F1, which was preferentially essential in pancreatic cancer cells, has been previously shown to regulate both pancreatic B-cell development and cancer growth by increasing the expression of PDK1 and PDK3 which results in increased aerobic glycolysis and growth in pancreatic cancers (41–43).